April 27, 2024 02:38 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
6.1 magnitude earthquake hits Taiwan, no immediate damages reported | Arjuna awardee CRPF officer found guilty of sexual harassment charges, faces dismissal | Opposition's dreams shattered: PM Modi on Supreme Court's VVPAT verdict | Supreme Court rejects plea seeking 100 pct votes verification on EVMs, rules out returning to ballot papers | Voting concludes in 88 constituencies with 61% turnout by 5 pm
CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

New Delhi: The Competition Commission of India (CCI) has approved the merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for the acquisition of approximately 15 percent equity shareholding of Biocon Biologics by Serum Institute Life Sciences.

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

London: British PM Boris Johnson has announced the Serum Institute of India (SII), the manufacturers of COVID-19 vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said.